Yarrow Bioscience Inc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-16.0M | $43.8M |
| FY2016 | — | $-29.4M | $4.0M |
| FY2017 | — | $68.6M | $10.2M |
| FY2018 | — | $92.2M | $27.9M |
| FY2019 | $32.7M | $17.6M | $43.8M |
| FY2020 | $33.2M | $37.5M | $57.6M |
| FY2021 | $0 | $48.6M | $42.3M |
| FY2022 | $0 | $31.2M | $30.9M |
| FY2023 | $0 | $88.7M | $30.6M |
| FY2024 | $0 | $52.1M | $19.9M |